not vested
RIDING THE 'SILVER TSUNAMI' TO NEW HIGHS
Today's chart looks at a biosciences stock that will benefit as the population ages...
There are an estimated 73 million Baby Boomers in the U.S., and by 2030, all will be at least age 65.
This "silver tsunami" is going to need more and more medical care and tests as they grow older. And today's company can help out with those medical needs...
Castle Biosciences (CSTL) is a $1 billion maker of skin-cancer tests. According to the American Cancer Society, the risk for melanoma increases as folks age...
And the World Health Organization labels non-melanoma skin cancer as one of the most common cancers in the world. Castle Biosciences has tests for types in both categories.
And it recently announced its new test for high-risk cutaneous squamous cell carcinoma is becoming available commercially.
As you can see, CSTL shares are up 116% in the past year. Shares recently hit new highs since going public last year.
As the Boomer generation ages, they'll need more medical testing, which will be a tailwind for Castle Biosciences' future...
Source: Daily Wealth